In January 2026, MEDIPOST Inc., the U.S. affiliate of South Korea‑based regenerative medicine and biotechnology company MEDIPOST Co., Ltd., successfully closed a $140 million funding round aimed at accelerating late-stage clinical development and operational growth. This capital infusion was led by Skylake Equity Partners and Crescendo Equity Partners, with participation from a leading Korean growth equity fund. The funds are intended to support MEDIPOST’s anticipated Phase III clinical trial of its allogeneic, umbilical cord blood-derived mesenchymal stem cell therapy for symptomatic cartilage defects in knee osteoarthritis, as well as expansion of its scientific, manufacturing, and infrastructure capabilities. [Read more…]
History of Cord Blood and Tissue Banking: Landmark Events and Pivotal Trends
The global cord blood industry came into existence in the early 1990’s with the formation of several leading cord blood banks in the USA, followed by the establishment of cord blood banks across the globe. However, the history of cord blood stem cell transplantation begins much earlier than that. [Read more…]
Pivotal Trends Impacting the Global Cord Blood and Tissue Industry in 2025
The cord blood industry came into existence in the early 1990’s with the formation of several cord blood banks in the U.S. and worldwide. It has been 40 years since it was first proposed that stem and progenitor cells were present in human cord blood. [Read more…]
Free Cord Blood Programs for Families in Need
In 2005, Congress passed the Stem Cell Therapeutic and Research Act, initiating the federally supported National Cord Blood Inventory (NCBI) program to increase the number of publicly available cord blood units for transplant. The law initially aimed to build an inventory of roughly 150,000 high-quality, diverse cord blood units to improve the likelihood of finding matches for patients in need. Today, the NCBI continues to contract with public cord blood banks across the United States, collecting and maintaining tens of thousands of units and making them searchable through the national registry for patients and physicians. [Read more…]
Cord Blood Banking Industry – Key Benchmarks to Track & Why to Care
The “Global Cord Blood & Tissue Banking Industry Report – Market Size, Segmentation, and Forecasts” market report reveals key benchmarks to track and why you should care. Benchmarks are critical to assess, because the  cord blood banking industry has matured substantially over the past few years, creating both serious threats and novel opportunities.
Therefore, judging individual company performance relative to the broader cord blood marketplace has become substantially more complex.
[Read more…]
- 1
- 2
- 3
- …
- 30
- Next Page »